Case report · 10 Aug 2026
Research articlePublished 19 Feb 2024
Respiratory Function at 3 Months after Hospital Discharge in Critically Ill Patients with COVID-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: Up to 20% of patients with COVID-19 get critically ill and require Intensive Care Unit (ICU) admission. At hospital discharge, most patients still have physical and mental limitations, which affect their quality of life. Pulmonary functional alterations in patients with COVID-19 vary from the absence of functional abnormalities to restrictive and diffusion impairments. We aimed to describe pulmonary function abnormalities as well as their impact on the 6-Minute Walk Test (6 MWT) and SF-36 Physical Component Summary (PCS) score in patients with COVID-19 at ≥ 3 months after hospital discharge. Methods: We included 65 patients aged ≥ 18 years with severe COVID-19 confirmed through real-time reverse transcriptase-polymerase chain reaction and admitted to the ICU between April 2020 and October 2021. Patients were evaluated at ≥ 3 months after hospital discharge using the 6 MWT, Pulmonary Function Tests (PFTs), and the PCS score. Results: Among the included patients, 27 patients had abnormal PFT findings, 21 (32.3%) had forced vital capacity<80%, 17 (26.1%) had forced expiratory volume in 1 s<80%, and 4 (6.1%) had a maximal mid-expiratory flow<65%. Compared with patients without abnormal PFT findings, patients with abnormal PFT findings were older and had significantly higher ferritin levels. There were no significant between-group differences in invasive and noninvasive respiratory support, mechanical ventilation duration, vasopressor use, and renal replacement therapy. However, compared with patients with normal PFT findings, patients with abnormal PFT findings showed a significantly lower 6-MWT score [78% (0.0–92) vs. 95% (75–100), p=0.01] and worse PCS scores [39.4 (32.1–51.3) vs. 52.0 (47.4–57.3), p=0.007]. There was an independent association between the PCS scores and PFT findings. Conclusion: We found that a significant proportion of patients present pulmonary functional alterations ≥ 3 months after discharge from the hospital after treatment for severe COVID-19; further, these alterations affect physical functional capacity and quality of life.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joaquim Henrique de Carvalho Lobato Filho”
- BylineArticles whose byline prints “Guilherme Bruzarca Tavares”
- BylineArticles whose byline prints “Francisco de Souza Trindade Neto”
- BylineArticles whose byline prints “Suellen Christine de Carvalho Souza”
- BylineArticles whose byline prints “Hugo Leonardo Freitas”
- BylineArticles whose byline prints “Adlyene Muniz da Silva Cruz”
- BylineArticles whose byline prints “Ana Chaves Silva”
- BylineArticles whose byline prints “Jose Raimundo Araujo de Azevedo”
